Prosight Management, LP
- SEC CIK
- 0001617201
- Latest filing
- Aug 14, 2026
MIRM holding history
Mirum Pharmaceuticals, Inc. in every 13F filed by Prosight Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MIRM overviewAll 13F holders of MIRMFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −200,000−100.0% | Sold out | Holders |
| Q2 2025 | 200,000 | $10.2M | 2.5% | −143,326−41.7% | Reduced | Holders |
| Q1 2025 | 343,326 | $15.5M | 5.1% | −107,801−23.9% | Reduced | Holders |
| Q4 2024 | 451,127 | $18.7M | 5.2% | −14,698−3.2% | Reduced | Holders |
| Q3 2024 | 465,825 | $18.2M | 4.6% | +151,025+48.0% | Added | Holders |
| Q2 2024 | 314,800 | $10.8M | 3.2% | −150,200−32.3% | Reduced | Holders |
| Q1 2024 | 465,000 | $11.7M | 3.2% | +171,699+58.5% | Added | Holders |
| Q4 2023 | 293,301 | $8.66M | 3.5% | −60,207−17.0% | Reduced | Holders |
| Q3 2023 | 353,508 | $11.2M | 3.5% | −321,492−47.6% | Reduced | Holders |
| Q2 2023 | 675,000 | $17.5M | 5.1% | +107,174+18.9% | Added | Holders |
| Q1 2023 | 567,826 | $13.6M | 6.5% | +259,050+83.9% | Added | Holders |
| Q4 2022 | 308,776 | $6.02M | 3.4% | +23,776+8.3% | Added | Holders |
| Q3 2022 | 285,000 | $5.99M | 3.3% | +123,473+76.4% | Added | Holders |
| Q2 2022 | 161,527 | $3.14M | 2.5% | +87,597+118.5% | Added | Holders |
| Q1 2022 | 73,930 | $1.63M | 1.1% | +73,930 | New | Holders |